Cervical cancer screening

A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test
Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process.
Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
Impact of breast cancer screening in a population with high spontaneous coverage with mammography
Impact of breast cancer screening in a population with high spontaneous coverage with mammography
Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial
Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round